Exploring Analyst Estimates for Phreesia (PHR) Q2 Earnings, Beyond Revenue and EPS

Wall Street analysts project Phreesia (PHR) will report a Q2 loss of -$0.07 per share, marking a 77.4% year-over-year improvement, with revenues anticipated to rise 14% to $116.45 million. The consensus EPS estimate has held steady over the last 30 days. Analysts also forecast growth across key revenue streams, including subscription, network solutions, and payment processing, alongside increases in average healthcare services clients and patient payment volume. PHR shares have significantly outperformed the S&P 500 over the past month, gaining 20.7%.

Analysis

Phreesia (PHR) is approaching its upcoming Q2 earnings with strong analyst expectations for both top-line growth and a significant move toward profitability. The consensus forecast projects a 14% year-over-year revenue increase to $116.45 million, while the anticipated loss per share of -$0.07 marks a substantial 77.4% improvement from the prior-year quarter. This growth is supported by positive momentum across all key revenue streams, with 'Network solutions' expected to lead at +17.9% YoY growth, followed by 'Subscription and related services' at +13.7% and 'Payment processing fees' at +10.3%. Underlying operational metrics reinforce this positive outlook, with projections for an increase in average healthcare clients to 4,475 and a rise in patient payment volume to $1.18 billion. The market has reacted favorably in anticipation, with PHR shares gaining 20.7% over the past month, significantly outperforming the S&P 500. The stability of the EPS estimate over the last 30 days suggests analyst conviction in this outlook.

Key Decisions for Investors

• Given the strong analyst consensus for double-digit revenue growth and a significant narrowing of losses, investors should treat the upcoming report as a key validation point, as high expectations are likely priced into the stock's recent 20.7% rally.
• Pay close attention to the performance of the 'Network solutions' segment, which is the fastest-growing revenue stream at a projected +17.9%; outperformance here could signal accelerating platform adoption and justify further upside.
• Despite optimistic forecasts, the stock's substantial recent run-up and neutral Zacks #3 (Hold) rating introduce the risk of a 'sell-the-news' reaction if the company only meets, rather than significantly beats, the elevated consensus estimates.